Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Docosanol bulk supplier for pharma manufacturers

Docosanol 10% Suppliers & Bulk Manufacturers

Available Forms: Creams

Available Strengths: 10%

Reference Brands: Abreva (USA)

Category: Anti Viral

Docosanol is a topical antiviral agent used for treatment of cold sores (fever blisters) on the face or lips caused by Herpes simplex infection. It works by preventing the fusion of the viral envelope with the host cell membrane, thereby reducing the viral entry, and thus shortens healing time and symptom duration.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Docosanol — third party manufacturing & bulk supply

Docosanol 10% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Docosanol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Docosanol →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Docosanol is used for the topical treatment of recurrent cold sores (herpes simplex virus type 1) on the lips and face. It helps shorten healing time and reduces symptoms such as tingling, burning, and itching when applied early during an outbreak.

Docosanol is a saturated 22-carbon fatty alcohol. It works by inhibiting the fusion between the herpes virus envelope and the host cell membrane, preventing viral entry and replication at the site of application.

The most widely known trade name for Docosanol is Abreva, available in a 10% topical cream formulation. Other regional brands may exist depending on the market.

Abreva, the leading brand of Docosanol, is manufactured by Haleon (formerly part of GlaxoSmithKline Consumer Healthcare).

The generic name of the product is docosanol.

The most common brand name is Abreva, along with other region-specific brands depending on the manufacturer.

Docosanol (Abreva) is manufactured by Haleon in its approved consumer healthcare production facilities. Generic docosanol creams are also produced in various countries by licensed manufacturers for regional markets.

Related Products

Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.